Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Study of circulating rare cells to detect and monitor myeloma and precursors finds D|CD138|BCMA-Memb phenotype most predictive; increases from MGUS-SMM-overt MM and distinguishes precursors from overt disease with 86% accuracy.”
Title: Characterizing circulating rare cells in peripheral blood for detecting and monitoring multiple myeloma and precursor states
Authors: Stephanie N. Shishido, Jeremy Mason, Mohamed Kamal, Sonia Maryam Setayesh, Amishi U. Vora, David Berrios, Luz Yurany Moreno Rueda, Krina Patel, Elisabet E. Manasanch, Robert Z. Orlowski, Peter Kuhn
You can read the Full Article in npj Precision Oncology.
You can find more posts featuring Robert Orlowski on OncoDaily.
